LIVER
Research
The field of transplantation is one of rapid growth and development. Texas Transplant Group Physicians are committed to research and offer clinical trials to patients as a means of improving quality of care now and in the future. Physicians with the Texas Transplant Physician Group are actively involved in different clinical trials that explore state-of-the-art therapies for a wide range of diseases.
A clinical trial is a research treatment regimen designed to answer specific questions about new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe, effective, and demonstrate an improvement over current treatment regimens.
The liver transplant program utilizes biopsy-directed Immunosuppression based on an organ biopsy; a clinician can modify or customize a patient’s medications to prescribe the least amount needed, minimizing painful and otherwise unwanted side effects: Immunosuppressive trials examine methods to prevent rejection in post-liver transplant patients.
Approximately four million people in the United States, or about one in 70-100, are infected with hepatitis C. Texas Transplant Institute offers trials to explore new treatment regimens for the viral infection. The liver transplant program is also actively involved in research related to surgical and medical management of hepatic cancer.
To view a list of current clinical trials and review a glossary of clinical terms click below:
Current Liver Failure/Transplant Trials
Glossary of Clinical Terms
RESEARCH DEPARTMENT CONTACT INFORMATION
Texas Transplant Institute
7711 Louis Pasteur, Suite 707
San Antonio, Texas 78229
(210) 575-4238